Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
6,781.00
-223.00 (-3.18%)
Jul 22, 2025, 3:30 PM JST

Chugai Pharmaceutical Revenue

Chugai Pharmaceutical had revenue of 288.46B JPY in the quarter ending March 31, 2025, with 21.74% growth. This brings the company's revenue in the last twelve months to 1.22T, up 17.96% year-over-year. In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T with 5.33% growth.

Revenue (ttm)
1,222.12B
Revenue Growth
+17.96%
P/S Ratio
9.43
Revenue / Employee
243.16M
Employees
5,026
Market Cap
11.53T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20241,170.61B59.24B5.33%
Dec 31, 20231,111.37B-148.58B-11.79%
Dec 31, 20221,259.95B260.19B26.02%
Dec 31, 2021999.76B212.81B27.04%
Dec 31, 2020786.95B100.76B14.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Takeda Pharmaceutical Company4,581.55B
Daiichi Sankyo Company1,886.26B
HOYA Corporation866.03B
Terumo1,036.17B
Otsuka Holdings2,393.18B
Astellas Pharma1,912.32B
Shionogi &438.27B
Olympus997.33B
Revenue Rankings